Proven track record of documentation review for accuracy and compliance to procedures essentially in analytical methods development, validation, transfer, stability studies, Design & Development.
A medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according to new findings from the University of Missouri School of Medicine published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
A new gene therapy treatment for Duchenne muscular dystrophy shows promise of not only arresting the decline of the muscles of those affected by this inherited genetic disease, but perhaps, in the future, repairing those muscles.
Early exposure to antibiotics can trigger long term susceptibility to asthma, according to new research from Monash University. Importantly the research team isolated a molecule produced by gut bacteria that in the future could potentially be trialed as a simple treatment, in the form of a dietary supplement, for children at risk of asthma to prevent them developing the disease.
M.Pharm, M.Sc. in Chemistry, Biochemistry, Pharmaceutical sciences, a relevant branch of Engineering or Life Sciences, or evidence of exceptional ability, preferable with experience in formulation research and development.
The candidate should be M.Pharm, M.Sc, M.Tech in Life Sciences, Biotechnology. Must be knowing animal handling. Desiring to do full time Ph.D. Should have participated in scientific conferences, training / workshop and presented their work.
The candidate should be M.Pharm. Pharm. Chem, Pharm. Analysis, Pharmaceutics, Pharmacognosy with high academic attainment with 1st class in graduate and post graduate examination.
Masters in Biotechnology, Life Sciences, Bioinformatics, Biochemistry, Allied biological Sciences discipline. PAN CSIR CANCER RESEARCH PROGRAM MAKING CANCER CARE AFFORDABLE: Empowering Women